Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Pain, Postoperative 4Pituitary Neoplasms 3Neoplasms 2Liver Neoplasms 2Delirium 2Central Nervous System Diseases 2Brain Neoplasms 2Supratentorial Neoplasms 1Sleep Initiation and Maintenance Disorders 1Rectal Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Pain 1Neuroinflammatory Diseases 1Neurofibromatoses 1Neurocognitive Disorders 1Lung Neoplasms 1Kidney Neoplasms 1Hypoxia 1Hydrocephalus 1Headache 1Epilepsy 1Colonic Neoplasms 1Chronic Pain 1Agnosia 1Abdominal Neoplasms 1Abdominal Cancer Surgery 1Abdominal Cancer Surgeries 1

Interventions

Levobupivacaine 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Abdominal Cancer Surgery × Dexmedetomidine × Clear all
NCT06695468 2024-11-19

Efficacy and Safety of Adding Dexmedetomidine to Levobupivacaine in Rectus Sheath Block Compared to Quadratus Lumborum Block in Patients Undergoing Lower Abdominal Cancer Surgery: A Randomized Clinical Trial

Assiut University

Phase 4 Not yet recruiting
122 enrolled

Abdominal Cancer Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡